JAAD Case Reports (Mar 2024)

Addendum to “Remittance of primary cutaneous CD30+ lymphoproliferative disorder in a patient on adalimumab”

  • Rosanne Ottevanger, MD,
  • Rutger C. Melchers, MD, PhD,
  • Koen D. Quint, MD, PhD

Journal volume & issue
Vol. 45
p. 34

Abstract

Read online

No abstracts available.

Keywords